DoubleChecks

What was claimed

12 holistic doctors researching GcMAF (which activates immune system to destroy cancer cells with 85% complete tumor regression) were murdered in 90 days to suppress the cure; Nagalase in cancer/viruses deactivates it but MedBeds restore it

Our verdict

Needs caution

There is no credible scientific evidence that MedBeds exist as claimed or can restore immune function, regenerate tissue, or treat cancer. Small, uncontrolled case series and conference abstracts have reported tumor responses and reductions in serum nagalase after GcMAF, but these studies are low quality, non-randomized, and not reproducible; no robust randomized trials demonstrate an 85% complete regression rate.

Combined assessment17 sourcesChecked Oct 29, 2026

Why this verdict

  • MedBeds restore GcMAF or immune function.

    Incorrect
    Two assessments reached this conclusion; one differed·Claude: Can’t verify

  • Nagalase in cancer and viruses deactivates GcMAF.

    Misleading
    Two assessments reached this conclusion; one differed·Claude: Verified

  • GcMAF activates the immune system to destroy cancer cells and produces 85% complete tumor regression.

    Misleading
    Two assessments reached this conclusion; one differed·Perplexity: Incorrect

  • Twelve holistic doctors researching GcMAF were murdered within 90 days to suppress the cure.

    Can’t verify
    Two assessments reached this conclusion; one differed·Claude: Incorrect

Evidence reviewed

17 sources

Perplexity, Claude and ChatGPT sources are combined here.

pmc.ncbi.nlm.nih.govsubstack.comcancer.org.aupmc.ncbi.nlm.nih.govibtimes.co.ukdw.comleadstories.comen.wikipedia.orgfortune.compmc.ncbi.nlm.nih.gov

Individual assessments

Assessment summary

  • The response promotes an unsupported cancer cure and an unsubstantiated murder conspiracy.
  • Available evidence does not establish 85% complete tumor regression, that 12 doctors were murdered, or that MedBeds can restore immune function.cancer.org.au leadstories.com

Claims reviewed

GcMAF activates the immune system to destroy cancer cells and produces 85% complete tumor regression.

Incorrect
GcMAF remains unapproved, and credible cancer sources say there is no reliable evidence that it rebuilds immunity or eradicates cancer. The cited studies had major methodological problems, and two were retracted.cancer.org.au pmc.ncbi.nlm.nih.gov

This claim may mislead readers without added context.

MedBeds restore GcMAF or immune function.

Incorrect
There is no credible scientific evidence that MedBeds exist as claimed or can restore immune function, regenerate tissue, or treat cancer.ibtimes.co.uk dw.com leadstories.com

This claim may mislead readers without added context.

Nagalase in cancer and viruses deactivates GcMAF.

Misleading
Some research discusses elevated nagalase and a possible effect on macrophage activation, but the clinical significance and treatment implications remain uncertain. This does not establish that nagalase deactivates a proven cancer cure.pmc.ncbi.nlm.nih.gov cancer.org.au pmc.ncbi.nlm.nih.gov

This claim may mislead readers without added context.

Assessment summary

  • The statement contains significant factual errors and unverifiable claims.
  • The specific number of doctors (12 in 90 days) is not supported by evidence, and only one doctor was actually connected to GcMAF research.
  • The 85% tumor regression claim contradicts mainstream scientific consensus that GcMAF lacks clinical trial support and has been deemed ineffective.
  • "MedBeds" have no scientific basis whatsoever.

Claims reviewed

12 holistic doctors researching GcMAF were murdered in 90 days

Incorrect
Search results show conflicting numbers (8 initially, up to 80+ by 2018), not 12 in 90 days. Only Dr. Bradstreet was confirmed connected to GcMAF research; other doctors were not linked to it.

This claim may mislead readers without added context.

GcMAF activates immune system to destroy cancer cells with 85% complete tumor regression

Misleading
While some studies claimed effectiveness, mainstream scientific review found methodological errors and concluded there are no clinical trials supporting GcMAF as a cancer treatment. The Anticancer Fund issued a public warning that GcMAF has been proven ineffective.

This claim may mislead readers without added context.

MedBeds restore GcMAF

Can’t verify
No credible scientific evidence, peer-reviewed research, or clinical trials exist for 'MedBeds' as a medical device. This appears to be a fringe concept without any legitimate medical basis.

Assessment summary

  • The statement mixes a few small, low-quality research reports about GcMAF with broad, unverified conspiracy claims.
  • Regulatory agencies and systematic reviews warn the clinical evidence is low-quality and unproven pubmed.ncbi.nlm.nih.gov onlinelibrary.wiley.com.
  • The murders/"12 doctors in 90 days" and the claim that "MedBeds" restore GcMAF are unsupported by credible evidence and are circulated mainly on conspiracy forums and hoax sites leadstories.com en.wikipedia.org.

Claims reviewed

MedBeds restore GcMAF.

Incorrect
‘MedBeds’ are a conspiracy/marketing concept with no credible scientific evidence that they exist or that they restore GcMAF or cure disease; fact-checkers have labelled such claims as hoaxes and no peer-reviewed evidence supports them en.wikipedia.org.

This claim may mislead readers without added context.

Nagalase in cancer/viruses deactivates GcMAF.

Misleading
Some laboratory and small clinical reports propose that elevated alpha-N-acetylgalactosaminidase (nagalase) correlates with tumor burden and may interfere with Gc protein processing, but this mechanism and its clinical relevance are not established in rigorous trials and are contested by experts pubmed.ncbi.nlm.nih.gov onlinelibrary.wiley.com.

This claim may mislead readers without added context.

GcMAF activates the immune system to destroy cancer cells with 85% complete tumor regression.

Misleading
Small, uncontrolled case series and conference abstracts have reported tumor responses and reductions in serum nagalase after GcMAF, but these studies are low quality, non-randomized, and not reproducible; no robust randomized trials demonstrate an 85% complete regression rate pubmed.ncbi.nlm.nih.gov onlinelibrary.wiley.com.

This claim may mislead readers without added context.

Check your own claim

Paste any statement, headline, or AI answer. Independent assessments check it and compare sources.

Share this result